Form 4: Trulieve Director Peter Healy Acquires 32,430 Stock Options
SEC Form 4
Director Peter Healy reports acquisition of 32,430 stock options in Trulieve Cannabis Corp.
Summary
- On March 25, 2025, Peter Healy, a director of Trulieve Cannabis Corp., acquired 32,430 stock options.
- The options have an exercise price of $4.03.
- The options are fully vested and expire on March 25, 2032.
- Following the transaction, Healy directly owns 32,430 derivative securities.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of stock option acquisition. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.
Positives
- The acquisition of stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, common in publicly traded companies like Trulieve in the cannabis industry. It provides transparency regarding the holdings and transactions of company insiders.
Stakeholder Impact
- The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 03/25/2025 | Date of transaction: Acquisition of stock options. |
| 03/25/2025 | Options are fully vested. |
| 03/28/2025 | Date of signature on the Form 4 filing. |
| 03/25/2032 | Expiration date of the stock options. |
Keywords
stock options, director, acquisition, Form 4, Trulieve Cannabis, TRUL, Peter Healy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.